APOBEC3A Cytidine Deaminase Induces RNA Editing in Monocytes and Macrophages

Total Page:16

File Type:pdf, Size:1020Kb

APOBEC3A Cytidine Deaminase Induces RNA Editing in Monocytes and Macrophages ARTICLE Received 8 Dec 2014 | Accepted 10 Mar 2015 | Published 21 Apr 2015 DOI: 10.1038/ncomms7881 OPEN APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages Shraddha Sharma1,*, Santosh K. Patnaik2,*, R. Thomas Taggart1, Eric D. Kannisto2, Sally M. Enriquez3, Paul Gollnick3 & Bora E. Baysal1 The extent, regulation and enzymatic basis of RNA editing by cytidine deamination are incompletely understood. Here we show that transcripts of hundreds of genes undergo site- specific C4U RNA editing in macrophages during M1 polarization and in monocytes in response to hypoxia and interferons. This editing alters the amino acid sequences for scores of proteins, including many that are involved in pathogenesis of viral diseases. APOBEC3A, which is known to deaminate cytidines of single-stranded DNA and to inhibit viruses and retrotransposons, mediates this RNA editing. Amino acid residues of APOBEC3A that are known to be required for its DNA deamination and anti-retrotransposition activities were also found to affect its RNA deamination activity. Our study demonstrates the cellular RNA editing activity of a member of the APOBEC3 family of innate restriction factors and expands the understanding of C4U RNA editing in mammals. 1 Department of Pathology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York 14203, USA. 2 Department of Thoracic Surgery, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York 14203, USA. 3 Department of Biological Sciences, University at Buffalo, State University of New York, Buffalo, New York 14260, USA. * These authors contributed equally to this work. Correspondence and requests for materials should be addressed to B.E.B. (email: [email protected]). NATURE COMMUNICATIONS | 6:6881 | DOI: 10.1038/ncomms7881 | www.nature.com/naturecommunications 1 & 2015 Macmillan Publishers Limited. All rights reserved. ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7881 NA editing is a co- or posttranscriptional process that alters Most importantly, we demonstrate that APOBEC3A, which transcript sequences without any change in the encoding belongs to the APOBEC3 family of CDAs, is an RNA-editing RDNA sequence1. Although various types of RNA editing enzyme. These findings significantly expand our understanding of have been observed in single-cell organisms to mammals, base C4U RNA editing and open new avenues of inquiry on the role modifications by deamination of adenine to inosine (A4I) or of APOBEC3 genes in viral and chronic diseases. cytidine to uracil (C4U) are the major types of RNA editing in higher eukaryotes. I and U are read as guanosine (G) and thymine Results (T), respectively, by the cellular machinery during messenger RNA translation and reverse transcription. RNA editing can SDHB RNA editing in IFN-treated MEPs and M1 macrophages. therefore alter amino acid sequences, thereby modifying and Similar to hypoxia, an IFN-rich microenvironment is another factor that monocytes are exposed to during inflammation. diversifying protein functions. Aberrant RNA editing is linked to 17 neuropsychiatric diseases such as epilepsy and schizophrenia, and IFNs also upregulate expression of APOBEC3 CDAs , candidate 4 chronic diseases such as cancer1. enzymes that may be responsible for the SDHB c.136C U RNA RNA-dependent ADAR1, ADAR2 and ADAR3 adenosine editing observed in monocytes. We therefore examined whether 4 deaminases, and APOBEC1 cytidine deaminase (CDA) are the IFNs induce SDHB c.136C U RNA editing. As shown in the left only known RNA-editing enzymes in mammals. RNA sequencing panel of Fig. 1a, treatment of MEPs with type 1 IFN (IFN1; studies suggest that A4I RNA editing affects hundreds of thousands of sites, although most of A4I RNA edits occur at a 70 Normoxia Hypoxia low level and in non-coding intronic and untranslated regions, 60 especially in the context of specific sequences such as Alu 60 2–4 elements .A4I editing of protein-coding RNA sequences at a 50 high level (420%) is rare and thought to occur predominantly in 50 the brain. Unlike A4I editing catalysed by adenosine 40 deaminases5, the prevalence and level of C4U RNA editing in 40 different types of cells and its enzymatic basis and regulation are 30 poorly understood. The activation-induced deaminase (AID), 30 apolipoprotein B-editing catalytic polypeptide-like (APOBEC) 136C>U editing (%) c. family and CDA proteins of mammals harbour the CDA motif 20 20 6 for hydrolytic deamination of C to U . The CDA enzyme is SDHB involved in the pyrimidine salvaging pathway. Although AID 10 10 causes C4U deamination of DNA, multiple studies have failed to 7 identify any RNA-editing activity for this protein . Humans have 0 0 – IFN1 γ 0 300 1,500 IFN1 (U ml–1) ten APOBEC genes (APOBEC1, 2, 3A–D, 3F–H and 4). APOBEC3 IFN proteins can deaminate cytidines in single-stranded (ss) DNA, 8 and although the APOBEC proteins bind RNA C4U 30 M0 deamination of RNA is known for only APOBEC1, with 14 M1 ) 9 2 M2 apolipoprotein B (APOB) mRNA as its physiological target . 12 25 C4U RNA editing alters hundreds of cytidines in chloroplasts and mitochondria of flowering plants, but the underlying 10 10 20 deaminating enzymes are unknown . 8 We have previously observed C4U editing of cytidine at c.136 6 (NCBI reference sequence NM_003000), which generates a 15 nonsense codon (R46X), in B6% of transcripts of the succinate 4 dehydrogenase B (SDHB) gene in normal peripheral blood c. 136C>U editing (%) c. 10 mononuclear cells (PBMCs) of humans11. SDHB encodes the 2 iron-sulfur subunit of mitochondrial respiratory complex II, 0 SDHB 5 which also participates in oxygen sensing and response12–14. M0 (log Expression change versus Mutations in SDH genes are associated with both hereditary and –2 non-hereditary paraganglioma and pheochromocytoma, renal 0 CCL2 CCL19 FCER2 MRC1 carcinoma and gastrointestinal stromal tumours15. More recently, we found that hypoxia (1% O2) enhances the C4U editing of Figure 1 | SDHB c.136C4U RNA editing in IFN-treated MEPs and M1 SDHB RNA at c.136 in monocytes, with an editing level of B18% macrophages (a) Mean and its s.e. (n ¼ 3) are shown on left for editing observed for monocyte-enriched PBMCs (MEPs) after 48 h of levels in MEPs optionally treated with IFN1 (600 U ml À 1), IFNg 16 À 1 hypoxia . Monocytes infiltrate tumours, atheromatous plaques (200 U ml ) and hypoxia (1% O2) for 24 h. The additive induction of SDHB and sites of infection and inflammation, which are characterized c.136C4U RNA editing by the IFNs and hypoxia is also depicted on right. by micro-environmental hypoxia. C4U RNA editing of SDHB Matched MEPs of seven individuals were cultured under normoxia or may therefore represent a hypoxia-adaptive mechanism that may hypoxia with 0, 300 or 1,500 U ml À 1 IFN1 for 24 h. Mean and its s.e. (n ¼ 7) have implications for the pathogenesis of chronic inflammatory for editing levels in the cells are shown. Editing level in cells treated with diseases. both hypoxia and IFN1 was higher than in cells treated with only hypoxia or To identify additional C4U RNA editing events in monocytes IFN1 (Wilcoxon test Po0.02, for both concentrations of IFN1). (b) M1 and and monocyte-derived macrophages (MEPs), we analyse their M2 macrophages were generated from unpolarized M0 macrophages whole transcriptome RNA sequences. We show that transcripts of derived from CD14 þ monocytes isolated from peripheral blood of three hundreds of genes including those implicated in viral pathogen- individuals. Mean and range (n ¼ 3) of expression of genes for markers of esis and Alzheimer’s disease are targets of editing in monocytes M1 and M2 polarization and SDHB c.136C4U editing levels in the cells are and macrophages. Such editing is regulated by oxygen, depicted. Gene expression was quantified by RT–PCR and normalized to interferons (IFNs) and also during macrophage polarization. that of ACTB. 2 NATURE COMMUNICATIONS | 6:6881 | DOI: 10.1038/ncomms7881 | www.nature.com/naturecommunications & 2015 Macmillan Publishers Limited. All rights reserved. NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7881 ARTICLE 600 U ml À 1) or IFNg (200 U ml À 1) for 24 h induced SDHB and 6.6% of the sites, respectively, whereas these two types of c.136C4U RNA editing in MEPs, both in normoxia and hypoxia editing respectively occurred at 10.6% and 86.5% of the sites in under 1% O2 (Mann–Whitney U-test Po0.01, comparing macrophages. A4G editing occurred at an overwhelming untreated and IFN-treated samples). The editing level in majority of the sites in MEPs, but only 1.0% of the A4G sites normoxic or hypoxic MEPs was increased B6-fold by IFN1 were in coding exons, causing 18 non-synonymous and 12 and B3-fold by IFNg, suggesting that the induction of RNA synonymous codon changes (Fig. 2c and Supplementary Table 5). editing with IFN1 was higher than with IFNg (Wilcoxon rank This is consistent with the known targeting of A4G RNA editing sum test Po0.03, comparing samples regardless of hypoxia to non-coding sequences4. On the other hand, 61.7% of the total treatment). An additive effect of IFNs and hypoxia on SDHB 211 C4U sites (in 199 genes) were in coding exons, causing 55 c.136C4U RNA editing was observed and this was confirmed in non-synonymous and 73 synonymous codon changes. C4U an independent experiment in which matched MEPs of seven editing accounted for 73.3% of all non-synonymous editing individuals were cultured under normoxia or hypoxia with 0, 300 upregulated by hypoxia in MEPs. In macrophages, 77.9% of the or 1,500 U ml À 1 IFN1 for 24 h. Editing level in cells treated with total 122 C4U sites (in 116 genes) were in coding exons, causing both hypoxia and IFN1 was higher than in cells treated with only 27 non-synonymous and 66 synonymous codon changes.
Recommended publications
  • Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignancy of the urinary system. The pathogenesis and effective diagnosis of ccRCC have become popular topics for research in the previous decade. In the current study, an integrated bioinformatics analysis was performed to identify core genes associated in ccRCC. An expression dataset (GSE105261) was downloaded from the Gene Expression Omnibus database, and included 26 ccRCC and 9 normal kideny samples. Assessment of the microarray dataset led to the recognition of differentially expressed genes (DEGs), which was subsequently used for pathway and gene ontology (GO) enrichment analysis.
    [Show full text]
  • Cytoplasmic Activation-Induced Cytidine Deaminase (AID) Exists in Stoichiometric Complex with Translation Elongation Factor 1Α (Eef1a)
    Cytoplasmic activation-induced cytidine deaminase (AID) exists in stoichiometric complex with translation elongation factor 1α (eEF1A) Julien Häsler, Cristina Rada, and Michael S. Neuberger1 Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom Edited by Frederick W. Alt, Howard Hughes Medical Institute, Harvard Medical School, Children’s Hospital Immune Disease Institute, Boston, MA, and approved October 12, 2011 (received for review April 27, 2011) Activation-induced cytidine deaminase (AID) is a B lymphocyte- results reveal that endogenous cytoplasmic AID partakes in a specific DNA deaminase that acts on the Ig loci to trigger antibody complex containing stoichiometric quantities of translation elon- gene diversification. Most AID, however, is retained in the cyto- gation factor 1α (eEF1A), with this association likely implicated in plasm and its nuclear abundance is carefully regulated because the regulation of AID’s intracellular trafficking. off-target action of AID leads to cancer. The nature of the cytosolic AID complex and the mechanisms regulating its release from the Results cytoplasm and import into the nucleus remain unknown. Here, we Flag-Tagging the Endogenous AID Locus in DT40 Cells. We generated show that cytosolic AID in DT40 B cells is part of an 11S complex derivatives of the DT40 B-cell line in which the endogenous AID and, using an endogenously tagged AID protein to avoid overex- locus was modified so as to incorporate a single Flag tag at the pression artifacts, that it is bound in good stoichiometry to the AID N terminus. To allow targeting of both alleles, one targeting translation elongation factor 1 alpha (eEF1A).
    [Show full text]
  • Comprehensive Identification and Characterization of Somatic Copy Number Alterations in Triple‑Negative Breast Cancer
    INTERNATIONAL JOURNAL OF ONCOLOGY 56: 522-530, 2020 Comprehensive identification and characterization of somatic copy number alterations in triple‑negative breast cancer ZAIBING LI1,2*, XIAO ZHANG3*, CHENXIN HOU4, YUQING ZHOU4, JUNLI CHEN1, HAOYANG CAI5, YIFENG YE3, JINPING LIU3 and NING HUANG1 1Department of Pathophysiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041; 2Department of Pathophysiology, School of Basic Medical Science, Southwest Medical University, Luzhou, Sichuan 646000; 3Department of Breast Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan 611731; 4West China Medical School, Sichuan University, Chengdu, Sichuan 610041; 5Center of Growth, Metabolism and Aging, Key Laboratory of Bio‑Resources and Eco‑Environment, College of Life Sciences, Sichuan University, Chengdu, Sichuan 610064, P.R. China Received January 30, 2019; Accepted August 30, 2019 DOI: 10.3892/ijo.2019.4950 Abstract. Triple-negative breast cancer (TNBC) accounts hierarchical clustering of tumors resulted in three main for ~15% of all breast cancer diagnoses each year. Patients subgroups that exhibited distinct CNA profiles, which with TNBC tend to have a higher risk for early relapse and may reveal the heterogeneity of molecular mechanisms in a worse prognosis. TNBC is characterized by extensive TNBC subgroups. These results will extend the molecular somatic copy number alterations (CNAs). However, the DNA understanding of TNBC and will facilitate the discovery of CNA profile of TNBC remains to be extensively investigated. therapeutic and diagnostic target candidates. The present study assessed the genomic profile of CNAs in 201 TNBC samples, aiming to identify recurrent CNAs that Introduction may drive the pathogenesis of TNBC.
    [Show full text]
  • High-Throughput Mutagenesis Reveals Functional Determinants for DNA Targeting by Activation-Induced Deaminase Kiran S
    9964–9975 Nucleic Acids Research, 2014, Vol. 42, No. 15 Published online 26 July 2014 doi: 10.1093/nar/gku689 High-throughput mutagenesis reveals functional determinants for DNA targeting by activation-induced deaminase Kiran S. Gajula1, Peter J. Huwe2,†, Charlie Y. Mo3,†, Daniel J. Crawford1, James T. Stivers4, Ravi Radhakrishnan2 and Rahul M. Kohli1,3,* 1Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA, 2Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA, 3Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA and 4Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA Received June 7, 2014; Revised July 16, 2014; Accepted July 16, 2014 ABSTRACT tional scanning and may find general utility for high- throughput analysis of protein function. Antibody maturation is a critical immune process governed by the enzyme activation-induced deam- inase (AID), a member of the AID/APOBEC DNA INTRODUCTION deaminase family. AID/APOBEC deaminases prefer- Enzyme families often share a central well-structured cat- entially target cytosine within distinct preferred se- alytic core, with different specificities among family mem- quence motifs in DNA, with specificity largely con- bers encoded by variable regions surrounding the active ferred by a small 9–11 residue protein loop that dif- site core (1,2). This mechanism for fulfilling the need for fers among family members. Here, we aimed to deter- specialization while maintaining core function is evident in / mine the key functional characteristics of this protein the family of AID APOBEC cytosine deaminase enzymes, loop in AID and to thereby inform our understanding which play an important role in adaptive and innate immu- nity.
    [Show full text]
  • Longitudinal Peripheral Blood Transcriptional Analysis of COVID-19 Patients
    medRxiv preprint doi: https://doi.org/10.1101/2020.05.05.20091355; this version posted May 8, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. 1 Longitudinal peripheral blood transcriptional analysis of COVID-19 patients 2 captures disease progression and reveals potential biomarkers 3 Qihong Yan1,5,†, Pingchao Li1,†, Xianmiao Ye1,†, Xiaohan Huang1,5,†, Xiaoneng Mo2, 4 Qian Wang1, Yudi Zhang1, Kun Luo1, Zhaoming Chen1, Jia Luo1, Xuefeng Niu3, Ying 5 Feng3, Tianxing Ji3, Bo Feng3, Jinlin Wang2, Feng Li2, Fuchun Zhang2, Fang Li2, 6 Jianhua Wang1, Liqiang Feng1, Zhilong Chen4,*, Chunliang Lei2,*, Linbing Qu1,*, Ling 7 Chen1,2,3,4,* 8 1Guangzhou Regenerative Medicine and Health-Guangdong Laboratory 9 (GRMH-GDL), Guangdong Laboratory of Computational Biomedicine, Guangzhou 10 Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 11 China 12 2Guangzhou Institute of Infectious Disease, Guangzhou Eighth People’s Hospital, 13 Guangzhou Medical University, Guangzhou, China 14 3State Key Laboratory of Respiratory Disease, National Clinical Research Center for 15 Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated 16 Hospital of Guangzhou Medical University, Guangzhou, China 17 4School of Medicine, Huaqiao University, Xiamen, China 18 5University of Chinese Academy of Science, Beijing, China 19 †These authors contributed equally to this work. 20 *To whom correspondence should be addressed: Ling Chen ([email protected]), 21 Linbing Qu ([email protected]), Chunliang Lei ([email protected]), Zhilong 22 Chen ([email protected]) NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
    [Show full text]
  • Functional Genomics Atlas of Synovial Fibroblasts Defining Rheumatoid Arthritis
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.16.20248230; this version posted December 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Functional genomics atlas of synovial fibroblasts defining rheumatoid arthritis heritability Xiangyu Ge1*, Mojca Frank-Bertoncelj2*, Kerstin Klein2, Amanda Mcgovern1, Tadeja Kuret2,3, Miranda Houtman2, Blaž Burja2,3, Raphael Micheroli2, Miriam Marks4, Andrew Filer5,6, Christopher D. Buckley5,6,7, Gisela Orozco1, Oliver Distler2, Andrew P Morris1, Paul Martin1, Stephen Eyre1* & Caroline Ospelt2*,# 1Versus Arthritis Centre for Genetics and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK 2Department of Rheumatology, Center of Experimental Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland 3Department of Rheumatology, University Medical Centre, Ljubljana, Slovenia 4Schulthess Klinik, Zurich, Switzerland 5Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK 6NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, University of Birmingham, Birmingham, UK 7Kennedy Institute of Rheumatology, University of Oxford Roosevelt Drive Headington Oxford UK *These authors contributed equally #corresponding author: [email protected] NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. 1 medRxiv preprint doi: https://doi.org/10.1101/2020.12.16.20248230; this version posted December 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Supplemental Information
    Supplemental information Dissection of the genomic structure of the miR-183/96/182 gene. Previously, we showed that the miR-183/96/182 cluster is an intergenic miRNA cluster, located in a ~60-kb interval between the genes encoding nuclear respiratory factor-1 (Nrf1) and ubiquitin-conjugating enzyme E2H (Ube2h) on mouse chr6qA3.3 (1). To start to uncover the genomic structure of the miR- 183/96/182 gene, we first studied genomic features around miR-183/96/182 in the UCSC genome browser (http://genome.UCSC.edu/), and identified two CpG islands 3.4-6.5 kb 5’ of pre-miR-183, the most 5’ miRNA of the cluster (Fig. 1A; Fig. S1 and Seq. S1). A cDNA clone, AK044220, located at 3.2-4.6 kb 5’ to pre-miR-183, encompasses the second CpG island (Fig. 1A; Fig. S1). We hypothesized that this cDNA clone was derived from 5’ exon(s) of the primary transcript of the miR-183/96/182 gene, as CpG islands are often associated with promoters (2). Supporting this hypothesis, multiple expressed sequences detected by gene-trap clones, including clone D016D06 (3, 4), were co-localized with the cDNA clone AK044220 (Fig. 1A; Fig. S1). Clone D016D06, deposited by the German GeneTrap Consortium (GGTC) (http://tikus.gsf.de) (3, 4), was derived from insertion of a retroviral construct, rFlpROSAβgeo in 129S2 ES cells (Fig. 1A and C). The rFlpROSAβgeo construct carries a promoterless reporter gene, the β−geo cassette - an in-frame fusion of the β-galactosidase and neomycin resistance (Neor) gene (5), with a splicing acceptor (SA) immediately upstream, and a polyA signal downstream of the β−geo cassette (Fig.
    [Show full text]
  • UNIVERSITY of CALIFORNIA RIVERSIDE Investigations Into The
    UNIVERSITY OF CALIFORNIA RIVERSIDE Investigations into the Role of TAF1-mediated Phosphorylation in Gene Regulation A Dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Cell, Molecular and Developmental Biology by Brian James Gadd December 2012 Dissertation Committee: Dr. Xuan Liu, Chairperson Dr. Frank Sauer Dr. Frances M. Sladek Copyright by Brian James Gadd 2012 The Dissertation of Brian James Gadd is approved Committee Chairperson University of California, Riverside Acknowledgments I am thankful to Dr. Liu for her patience and support over the last eight years. I am deeply indebted to my committee members, Dr. Frank Sauer and Dr. Frances Sladek for the insightful comments on my research and this dissertation. Thanks goes out to CMDB, especially Dr. Bachant, Dr. Springer and Kathy Redd for their support. Thanks to all the members of the Liu lab both past and present. A very special thanks to the members of the Sauer lab, including Silvia, Stephane, David, Matt, Stephen, Ninuo, Toby, Josh, Alice, Alex and Flora. You have made all the years here fly by and made them so enjoyable. From the Sladek lab I want to thank Eugene, John, Linh and Karthi. Special thanks go out to all the friends I’ve made over the years here. Chris, Amber, Stephane and David, thank you so much for feeding me, encouraging me and keeping me sane. Thanks to the brothers for all your encouragement and prayers. To any I haven’t mentioned by name, I promise I haven’t forgotten all you’ve done for me during my graduate years.
    [Show full text]
  • TITLE PAGE Oxidative Stress and Response to Thymidylate Synthase
    Downloaded from molpharm.aspetjournals.org at ASPET Journals on October 2, 2021 -Targeted -Targeted 1 , University of of , University SC K.W.B., South Columbia, (U.O., Carolina, This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted.
    [Show full text]
  • Transcriptomic and Proteomic Profiling Provides Insight Into
    BASIC RESEARCH www.jasn.org Transcriptomic and Proteomic Profiling Provides Insight into Mesangial Cell Function in IgA Nephropathy † † ‡ Peidi Liu,* Emelie Lassén,* Viji Nair, Celine C. Berthier, Miyuki Suguro, Carina Sihlbom,§ † | † Matthias Kretzler, Christer Betsholtz, ¶ Börje Haraldsson,* Wenjun Ju, Kerstin Ebefors,* and Jenny Nyström* *Department of Physiology, Institute of Neuroscience and Physiology, §Proteomics Core Facility at University of Gothenburg, University of Gothenburg, Gothenburg, Sweden; †Division of Nephrology, Department of Internal Medicine and Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan; ‡Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan; |Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; and ¶Integrated Cardio Metabolic Centre, Karolinska Institutet Novum, Huddinge, Sweden ABSTRACT IgA nephropathy (IgAN), the most common GN worldwide, is characterized by circulating galactose-deficient IgA (gd-IgA) that forms immune complexes. The immune complexes are deposited in the glomerular mesangium, leading to inflammation and loss of renal function, but the complete pathophysiology of the disease is not understood. Using an integrated global transcriptomic and proteomic profiling approach, we investigated the role of the mesangium in the onset and progression of IgAN. Global gene expression was investigated by microarray analysis of the glomerular compartment of renal biopsy specimens from patients with IgAN (n=19) and controls (n=22). Using curated glomerular cell type–specific genes from the published literature, we found differential expression of a much higher percentage of mesangial cell–positive standard genes than podocyte-positive standard genes in IgAN. Principal coordinate analysis of expression data revealed clear separation of patient and control samples on the basis of mesangial but not podocyte cell–positive standard genes.
    [Show full text]
  • Appendix 2. Significantly Differentially Regulated Genes in Term Compared with Second Trimester Amniotic Fluid Supernatant
    Appendix 2. Significantly Differentially Regulated Genes in Term Compared With Second Trimester Amniotic Fluid Supernatant Fold Change in term vs second trimester Amniotic Affymetrix Duplicate Fluid Probe ID probes Symbol Entrez Gene Name 1019.9 217059_at D MUC7 mucin 7, secreted 424.5 211735_x_at D SFTPC surfactant protein C 416.2 206835_at STATH statherin 363.4 214387_x_at D SFTPC surfactant protein C 295.5 205982_x_at D SFTPC surfactant protein C 288.7 1553454_at RPTN repetin solute carrier family 34 (sodium 251.3 204124_at SLC34A2 phosphate), member 2 238.9 206786_at HTN3 histatin 3 161.5 220191_at GKN1 gastrokine 1 152.7 223678_s_at D SFTPA2 surfactant protein A2 130.9 207430_s_at D MSMB microseminoprotein, beta- 99.0 214199_at SFTPD surfactant protein D major histocompatibility complex, class II, 96.5 210982_s_at D HLA-DRA DR alpha 96.5 221133_s_at D CLDN18 claudin 18 94.4 238222_at GKN2 gastrokine 2 93.7 1557961_s_at D LOC100127983 uncharacterized LOC100127983 93.1 229584_at LRRK2 leucine-rich repeat kinase 2 HOXD cluster antisense RNA 1 (non- 88.6 242042_s_at D HOXD-AS1 protein coding) 86.0 205569_at LAMP3 lysosomal-associated membrane protein 3 85.4 232698_at BPIFB2 BPI fold containing family B, member 2 84.4 205979_at SCGB2A1 secretoglobin, family 2A, member 1 84.3 230469_at RTKN2 rhotekin 2 82.2 204130_at HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 81.9 222242_s_at KLK5 kallikrein-related peptidase 5 77.0 237281_at AKAP14 A kinase (PRKA) anchor protein 14 76.7 1553602_at MUCL1 mucin-like 1 76.3 216359_at D MUC7 mucin 7,
    [Show full text]
  • Temporal Proteomic Analysis of HIV Infection Reveals Remodelling of The
    1 1 Temporal proteomic analysis of HIV infection reveals 2 remodelling of the host phosphoproteome 3 by lentiviral Vif variants 4 5 Edward JD Greenwood 1,2,*, Nicholas J Matheson1,2,*, Kim Wals1, Dick JH van den Boomen1, 6 Robin Antrobus1, James C Williamson1, Paul J Lehner1,* 7 1. Cambridge Institute for Medical Research, Department of Medicine, University of 8 Cambridge, Cambridge, CB2 0XY, UK. 9 2. These authors contributed equally to this work. 10 *Correspondence: [email protected]; [email protected]; [email protected] 11 12 Abstract 13 Viruses manipulate host factors to enhance their replication and evade cellular restriction. 14 We used multiplex tandem mass tag (TMT)-based whole cell proteomics to perform a 15 comprehensive time course analysis of >6,500 viral and cellular proteins during HIV 16 infection. To enable specific functional predictions, we categorized cellular proteins regulated 17 by HIV according to their patterns of temporal expression. We focussed on proteins depleted 18 with similar kinetics to APOBEC3C, and found the viral accessory protein Vif to be 19 necessary and sufficient for CUL5-dependent proteasomal degradation of all members of the 20 B56 family of regulatory subunits of the key cellular phosphatase PP2A (PPP2R5A-E). 21 Quantitative phosphoproteomic analysis of HIV-infected cells confirmed Vif-dependent 22 hyperphosphorylation of >200 cellular proteins, particularly substrates of the aurora kinases. 23 The ability of Vif to target PPP2R5 subunits is found in primate and non-primate lentiviral 2 24 lineages, and remodeling of the cellular phosphoproteome is therefore a second ancient and 25 conserved Vif function.
    [Show full text]